EridanusPills logotype

Cart: Your cart is empty

    Payment Methods:
  • Visa payment logo
  • Mastercard payment logo

Hours of Operation 24/7

Buy Carvedigamma

25 mg, 12.5 mg, 6.25 mg

Carvedigamma tablets 25 mg, 12.5 mg, 6.25 mg image

Active ingredient: carvedilol

Buy Now
Categories of CarvedigammaHeart Disease
Average price (USD)$1.54
Manufacturer country (Worldwide Sale)Bosnia & Herzegowina, Bulgaria, Georgia, Germany, Hungary, Lithuania, Poland, Serbia, Slovakia
Medication ClassNon-cardioselective beta blockers

Carvedigamma medications over the counter

Carvedigamma treatment was maintained beyond 3 medical, worsening heart failure was http://eridanuspills.com/hair-loss-medications/finster.php less cure in subjects treated with carvedilol than with placebo. Carvedilol can cause dangerously low blood pressure, which may cause you to lose consciousness. Nightmares and panic disorder associated with carvedilol overdose.

Side Effects

Possible side effects of Carvedigamma include:

  • dark urine
  • slow heartbeat
  • diarrhea
  • inability to have or keep an erection
  • shortness of breath
  • difficulty with moving

Used for

Carvedigamma is used to treat diseases such as: Angina, Atrial Fibrillation, Heart Failure, High Blood Pressure, Left Ventricular Dysfunction.

How to Use

  • Side effects, drug interactions, pregnancy safety, and warnings and precautions should be reviewed prior to taking this medication.

Dosage & Overdose

Because strategies for the management of overdose are continually evolving, it is advisable to contact a poison control center to determine the latest recommendations for the management of an overdose of any drug. You will find the directions for taking the doses printed on the label of the pack, to remind you about what the doctor said to you.

Warnings

  • When you use this medication, you also need to make lifestyle changes, including switching to a diet low in fat and cholesterol, quitting smoking, and increasing the amount of exercise you do.
  • Visual fields should be monitored in patients with macroprolactinoma.